Literature DB >> 8385948

Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase.

D S Shewach1, D C Liotta, R F Schinazi.   

Abstract

The two enantiomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) and their 5-fluoro analogs (FTC) were found to be good substrates for human 2'-deoxycytidine kinase with Km values in the 5.7 to 42.1 microM range. The affinity of the (-)-enantiomers was greater than that of the (+)-compounds. These results may explain the greater in vitro antiviral potency against human immunodeficiency virus and hepatitis B virus of the (-)-enantiomers when compared to their (+)-counterparts. The (+)- and (-)-enantiomers of FTC and BCH-189 are the first nucleoside analogs for which we have observed lower apparent kinetic constants for this enzyme in the presence of ATP compared to UTP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385948     DOI: 10.1016/0006-2952(93)90058-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  24 in total

1.  Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.

Authors:  Ghazia Asif; Selwyn J Hurwitz; Giuseppe Gumina; Chung K Chu; Harold M McClure; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Antiviral and cellular metabolism interactions between Dexelvucitabine and lamivudine.

Authors:  Brenda I Hernandez-Santiago; Judy S Mathew; Kim L Rapp; Jason P Grier; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

3.  Systematic exploration of active site mutations on human deoxycytidine kinase substrate specificity.

Authors:  Pinar Iyidogan; Stefan Lutz
Journal:  Biochemistry       Date:  2008-03-25       Impact factor: 3.162

4.  L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity?

Authors:  A Verri; A Montecucco; G Gosselin; V Boudou; J L Imbach; S Spadari; F Focher
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

5.  Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase.

Authors:  L L Bennett; P W Allan; G Arnett; Y F Shealy; D S Shewach; W S Mason; I Fourel; W B Parker
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

6.  Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.

Authors:  J J Rahn; D M Kieller; D L Tyrrell; W P Gati
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

7.  Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice.

Authors:  J Balzarini; T Vahlenkamp; H Egberink; K Hartmann; M Witvrouw; C Pannecouque; P Casara; J F Navé; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

8.  Pharmacodynamics of (-)-beta-2',3'-dideoxy-3'-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans.

Authors:  S J Hurwitz; B C Tennant; B E Korba; J L Gerin; R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

9.  Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2.2.15 (subclone P5A) cells.

Authors:  M T Paff; D R Averett; K L Prus; W H Miller; D J Nelson
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro.

Authors:  G Gosselin; R F Schinazi; J P Sommadossi; C Mathé; M C Bergogne; A M Aubertin; A Kirn; J L Imbach
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.